AVNS
Avanos Medical, Inc. Healthcare - Medical Devices Investor Relations →
Avanos Medical, Inc. (AVNS) closed at $24.66 as of 2026-05-01, trading 25.2% above its 200-week moving average of $19.69. The stock moved further from the line this week, up from 25.1% last week. With a 14-week RSI of 84, AVNS is in overbought territory.
Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.36 ratio) is neutral — neither side is clearly dominating.
Over the past 553 weeks of data, AVNS has crossed below its 200-week moving average 9 times. On average, these episodes lasted 43 weeks. The average one-year return after crossing below was -3.7%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $1151 million, AVNS is a small-cap stock. The company generates a free cash flow yield of 4.0%. Return on equity stands at -9.1%. The stock trades at 1.5x book value.
Over the past 10.7 years, a hypothetical investment of $100 in AVNS would have grown to $86, compared to $449 for the S&P 500. AVNS has returned -1.4% annualized vs 15.1% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 1 open-market purchase totaling $659,300.
Free cash flow has been declining at a -15.6% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: AVNS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After AVNS Crosses Below the Line?
Across 9 historical episodes, buying AVNS when it crossed below its 200-week moving average produced an average return of +0.4% after 12 months (median -15.0%), compared to +12.7% for the S&P 500 over the same periods. 44% of those episodes were profitable after one year. After 24 months, the average return was +14.1% vs +40.0% for the index.
Each line shows $100 invested at the moment AVNS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
AVNS has crossed below its 200-week MA 9 times with an average 1-year return of +-3.7% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 2015 | Aug 2016 | 44 | 37.9% | +20.3% | -14.4% |
| Sep 2016 | Nov 2016 | 10 | 10.9% | +31.2% | -29.4% |
| May 2017 | May 2017 | 2 | 0.6% | +47.7% | -31.9% |
| Dec 2018 | Jan 2019 | 1 | 4.1% | -14.9% | -38.1% |
| Mar 2019 | Mar 2019 | 1 | 1.3% | -48.3% | -39.7% |
| May 2019 | Jun 2019 | 3 | 9.3% | -31.5% | -40.0% |
| Jul 2019 | Oct 2019 | 14 | 22.2% | -17.1% | -38.4% |
| Nov 2019 | Nov 2020 | 54 | 50.6% | +11.9% | -30.6% |
| May 2021 | Apr 2026 | 258 | 53.0% | -32.6% | -40.1% |
| Average | 43 | — | +-3.7% | — |
Frequently Asked Questions
Is AVNS below its 200-week moving average?
No. Avanos Medical, Inc. (AVNS) is currently 25.2% above its 200-week moving average of $19.69. It would need to fall to $19.69 to cross below the line.
What is AVNS's 200-week moving average price?
Avanos Medical, Inc.'s 200-week moving average is $19.69 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when AVNS drops below its 200-week moving average?
AVNS has crossed below its 200-week moving average 9 times in our data. The average one-year return after these crossings was -3.7%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 43 weeks on average.
Is AVNS a good value right now?
Here's what our data says about AVNS as of 2026-05-01: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 84 (overbought). Free cash flow yield is 4.0%. Return on equity is -9.1%. Price-to-book is 1.5x. This is not a buy or sell recommendation — always do your own research.
How does AVNS compare to the S&P 500?
Over the past 10.7 years, $100 invested in AVNS would have grown to $86, compared to $449 for the S&P 500. That's -1.4% annualized vs 15.1% for the index. AVNS has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01